Relationships between serum lipids and cholelithiasis: observations in the GREPCO study

  • M. Angelico
  • the GREPCO Group

Abstract

The association between coronary heart disease (CHD) and gallstone disease (GD) has been a matter of much controversy over recent decades1,2. Due to the high prevalence of both diseases in the free-living population, the coexistence of CHD and GD is relatively easily observed. However, demonstration of a real association based on epidemiological data is lacking3, as it requires screening of population samples too large to be examined with objective diagnostic procedures.

Keywords

Serum Cholesterol Serum Lipid Serum Triglyceride Total Serum Cholesterol Serum Cholesterol Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Friedman, G. D. (1968). The relationship between coronary heart disease and gallbladder disease: a critical review. Ann. Intern. Med., 68, 222–235Google Scholar
  2. 2.
    Kaye, M. O. and Kern, F. (1971). Clinical relationship of gallstones. Lancet, 1, 1228PubMedCrossRefGoogle Scholar
  3. 3.
    Bennion, L. J. and Grundy, S. M. (1978). Risk factors for the development of cholelithiasis in man. N. Engl. J. Med., 299, 1221–1227PubMedCrossRefGoogle Scholar
  4. 4.
    Glueck, C. J. (1983). Relationship of lipid disorders to coronary heart disease. Am. J. Med., 74 (5A), Suppl. 10Google Scholar
  5. 5.
    Schwartz, C. C., Halloran, L. G., Vlahcevic, Z. R., Gregory, D. H. and Swell, L. (1978). Preferential utilization of free cholesterol from high density lipoprotein for biliary cholesterol secretion in man. Science, 200, 62PubMedCrossRefGoogle Scholar
  6. 6.
    Thornton, J. R., Heaton, K. W. and McFarlane, D. G. (1981). A relation between high density lipoprotein cholesterol and bile cholesterol saturation. Br. Med. J., 283, 1352–1354CrossRefGoogle Scholar
  7. 7.
    Ahlberg, J., Angelin, B., Einarsson, K., Hellström, K. and Leijd, B. (1980). Biliary lipid composition in normo- and hyperlipoproteinemia. Gastroenterology, 79, 90–94PubMedGoogle Scholar
  8. 8.
    Petitti, D. B., Friedman, G. D. and Klatsky, A. L. (1981). Association of a history of gallbladder disease with a reduced concentration of high density lipoprotein cholesterol. N. Engl. J. Med., 304, 1396–1398PubMedCrossRefGoogle Scholar
  9. 9.
    Grepco (Gruppo Romano per l’Epidemiologia e la Prevenzione della Colelitiasi). Prevalence of gallstone disease in an Italian adult female population. Am. J. Epidemiol. (In press)Google Scholar
  10. 10.
    Morisi, G., Macchia, T., Angelico, F., Pacioni, F. and Zucca, A. (1979). Determinazione automatica di trigliceridi, colesterolo, glucosio e acido urico. Prospettive di impiego in screenings di medicina preventiva. Ann. 1st. Sup. Sanità, 15, 122Google Scholar
  11. 11.
    Manual of Laboratory Operations, Lipid Research Clinic Program (1974). DHEW Publ. N. (NHI) 75–328, Vol. 1, page 56Google Scholar
  12. 12.
    Remington, R. D. and Schork, M. A. (1970). In Statistics with Applications to the Biological and Health Sciences (Englewood Cliffs, NJ: Prentice-Hall)Google Scholar
  13. 13.
    BMDP Statistical Software (1981). Department of Biomathematics, University of California, Los Angeles. (University of California Press)Google Scholar
  14. 14.
    The Coronary Drug Project Research Group (1977). Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. N. Engl. J. Med., 296, 1185CrossRefGoogle Scholar
  15. 15.
    Ahlberg, J., Angelin, B., Einarsson, K., Hellström, K. and Leijd, B. (1979). Prevalence of gallbladder disease in hyperlipoproteinemia. Dig. Dis. Sci., 24, 459PubMedCrossRefGoogle Scholar
  16. 16.
    Horn, G. (1956). Observations on the aethiology of cholelithiasis. Br. Med. J., 2, 732PubMedCrossRefGoogle Scholar
  17. 17.
    The Lipid Research Clinics (1980). Population Studies Data Book, vol. 1. The prevalence study. US Department of Health and Human Services. NIH publication, 80, 1527Google Scholar
  18. 18.
    Sampliner, R. E., Bennett, P. H., Comess, L. J., Rose, F. A. and Burch, T. A. (1970). Gallbladder disease in Pima Indians. N. Engl. J. Med., 283, 1358–1364PubMedCrossRefGoogle Scholar
  19. 19.
    Pertsemlidis, D., Panveliwalla, D. and Ahrens, E. H. Jr. (1974). Effects of Clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology, 66, 565–573PubMedGoogle Scholar
  20. 20.
    Bateson, M. C., Maclean, D., Ross, P. E. and Bouchier, I. A. D. (1978). Clofibrate therapy and gallstone induction. Dig. Dis., 23, 623CrossRefGoogle Scholar
  21. 21.
    Sturdevant, R. A. L., Pearce, M. L. and Dayton, S. (1973). Increased prevalence of cholelithiasis in men ingesting a serum cholesterol-lowering-diet. N. Engl. J. Med., 288, 24–27PubMedCrossRefGoogle Scholar
  22. 22.
    Miettinen, M., Turpeinen, D., Karvonen, M. J. et al. (1976). Prevalence of cholelithiasis in men and women ingesting a serum cholesterol lowering diet. Ann. Clin. Res., 8, 111–116PubMedGoogle Scholar
  23. 23.
    Albers, J. J., Grundy, S. H., Cleary, P. A., Small, D. H., Lachin, J. M., Schoenfield, L. J. and The National Cooperative Gallstone Study Group (1982). The effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology, 82, 638Google Scholar
  24. 24.
    Angelin, B., Einarsson, K., Hellström, K. and Kallner, M. (1976). Elimination of cholesterol in hyperlipoproteinemia. Clin. Sci. Mol. Med., 51, 393PubMedGoogle Scholar
  25. 25.
    Kadziolka, R., Nilsson, S. and Schersten, T. (1977). Prevalence of hyperlipoproteinemia in men with gallstone disease. Scand. J. Gastroenterol., 12, 353PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1984

Authors and Affiliations

  • M. Angelico
  • the GREPCO Group

There are no affiliations available

Personalised recommendations